Salarius Pharmaceuticals Correlations
SLRX Stock | USD 2.69 0.07 2.67% |
The current 90-days correlation between Salarius Pharmaceuticals and FWBI Old is -0.13 (i.e., Good diversification). The correlation of Salarius Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Salarius Pharmaceuticals Correlation With Market
Average diversification
The correlation between Salarius Pharmaceuticals and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Salarius |
Moving together with Salarius Stock
Moving against Salarius Stock
0.32 | BIAF | bioAffinity Technologies, | PairCorr |
0.32 | UTMD | Utah Medical Products Earnings Call Next Week | PairCorr |
0.31 | PPERF | Bank Mandiri Persero | PairCorr |
0.52 | PG | Procter Gamble Earnings Call Tomorrow | PairCorr |
0.4 | HPQ | HP Inc | PairCorr |
0.39 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
0.38 | INTC | Intel Earnings Call This Week | PairCorr |
0.38 | VZ | Verizon Communications Earnings Call Tomorrow | PairCorr |
0.37 | AA | Alcoa Corp | PairCorr |
0.33 | TRV | The Travelers Companies | PairCorr |
0.31 | T | ATT Inc Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Salarius Stock performing well and Salarius Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Salarius Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AKTX | 5.39 | (0.87) | 0.00 | 1.08 | 0.00 | 10.68 | 47.27 | |||
AXLA | 3.96 | (0.97) | 0.00 | 44.51 | 0.00 | 7.69 | 39.29 | |||
MGTA | 2.62 | 0.11 | 0.02 | (5.67) | 3.40 | 5.88 | 16.99 | |||
HSTO | 5.03 | (1.01) | 0.00 | (0.96) | 0.00 | 6.75 | 131.40 | |||
TMBR | 4.23 | 0.35 | 0.06 | 0.51 | 5.18 | 13.02 | 37.57 | |||
ARTLW | 23.23 | 2.80 | 0.09 | (0.89) | 23.45 | 68.38 | 147.53 | |||
NTRB | 4.11 | (0.87) | 0.00 | 1.49 | 0.00 | 9.76 | 29.61 | |||
ALRN | 4.00 | (0.53) | 0.00 | 61.99 | 0.00 | 8.06 | 24.38 | |||
FWBI | 5.73 | (1.80) | 0.00 | 6.98 | 0.00 | 8.65 | 65.42 | |||
SABS | 6.45 | 0.97 | 0.14 | (44.18) | 6.44 | 19.02 | 65.66 |
Salarius Pharmaceuticals Corporate Executives
Elected by the shareholders, the Salarius Pharmaceuticals' board of directors comprises two types of representatives: Salarius Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Salarius. The board's role is to monitor Salarius Pharmaceuticals' management team and ensure that shareholders' interests are well served. Salarius Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Salarius Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.